Evidence map›Paper›PMID 41657734›Full record

ReviewFrontiers in molecular biosciences2026

Advances in protein dot blot: principles, technical specifics, applications, and future perspectives.

Juan Lu, Feng-Yi Mai, Xin-Yu Li, Wen-Tao Yang, Jing-Rong Liang, Xing-Long Li, Jie Guo, Chen-Guang Li

Abstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juan Lu *Shenzhen Hospital of Southern Medical University, Shenzhen, China.
Feng-Yi Mai *Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Xin-Yu Li *Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wen-Tao YangShenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Jing-Rong LiangShenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Xing-Long LiShenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Jie GuoDepartment of Rheumatology & Immunology, Shenzhen Second People's Hospital, Shenzhen, China.
Chen-Guang LiShenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein dot blot is an efficient immunoblotting technique enabling qualitative/semi-quantitative protein analysis without electrophoresis, relying on antigen-antibody binding. Its workflow involves direct sample spotting on membranes, blocking, antibody incubation, and signal detection, completing within 3-5 h. Advantages include simplicity, high throughput, micro-sample compatibility, and cost-effectiveness, supporting basic life science research and clinical testing. However, it faces limitations like narrow dynamic range, inability to resolve protein variants, susceptibility to non-specific binding, and sensitivity to operational variables. This review systematically elaborates on its principles and procedures, analyzes key factors influencing sensitivity, and repeatability, and focuses on recent application progress in protein analysis, clinical biomarker detection, and food safety, along with technical innovations. It aims to provide comprehensive references for researchers and a theoretical basis for further optimization, with future advancements likely involving nanomaterial-based signal amplification, engineered antibodies, and integration with microfluidics or mass spectrometry to expand utility in biomedicine and public health.

Indexed as

applicationshigh-throughput screeningprotein detectionprotein dot blottechnical specifics

Identifiers

PMID41657734
PMCPMC12877402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.